Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

13.7% CAGR Predicted for China’s Pharma Market over 5 Years

publication date: Oct 6, 2010
China’s pharmaceutical market will grow at a CAGR of 13.7% in dollar terms over the next five years (2010-14), taking its combined sales of OTC and prescription drugs from $46.8 billion in 2009 to $88.7 billion in 2014. The jump equates to a 12.4% CAGR in local currency, which is lower because of an expected rise in the value of the yuan. The prediction was made by Business Monitor International.  More details....


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital